Original ArticleAlemtuzumab and Sirolimus in Renal Transplantation: Six-Year Results of a Single-Arm Prospective Pilot Study
Under a Creative Commons license
open archive
Key words:
Calcineurin inhibitor toxicity
Campath-1H
renal transplantation
sirolimus
steroid-free immunosuppression
Abbreviations
CMV
cytomegalovirus
CNI
calcineurin inhibitor
%cRF
calculated reaction frequency
DBD
donation after brain death
DCD
donation after cardiac death
eGFR
estimated GFR
PTLD
posttransplant lymphoproliferative disorder
Cited by (0)
Copyright © 2014 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.